Rnd-flowers
ETFs Holding GILD » GILD Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
01/12/2018 $79.34 $79.40 $78.65 $79.02 6.37M
01/16/2018 $79.75 $81.59 $79.52 $80.25 11.75M
01/17/2018 $80.71 $82.07 $80.21 $81.74 11.16M
01/18/2018 $81.47 $81.65 $80.77 $81.17 8.53M
01/19/2018 $81.30 $81.53 $80.37 $80.98 6.96M
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co. focuses on human immunodeficiency virus, liver diseases such as chronic hepatitis C virus infection and chronic hepatitis B virus infection, cardiovascular, hematology/oncology and inflammation/respiratory. Co. owns or has rights to various trademarks, copyrights and trade names used in its business, including: GILEAD®, GILEAD SCIENCES®, AMBISOME®, CAYSTON®, COMPLERA®, DESCOVY®, EMTRIVA®, EPCLUSA®, EVIPLERA®, GENVOYA®, HARVONI®, HEPSERA®, LETAIRIS®, ODEFSEY®, RANEXA®, SOVALDI®, STRIBILD®, TRUVADA®, TYBOST®, VEMLIDY®, VIREAD®, VITEKTA®, VOLIBRIS® and ZYDELIG®.
GILD historical stock prices picture
Gilead Sciences (GILD) has the following price history information. Looking back at GILD historical stock prices for the last five trading days, on January 12, 2018, GILD opened at $79.34, traded as high as $79.40 and as low as $78.65, and closed at $79.02. Trading volume was a total of 6.37M shares. On January 16, 2018, GILD opened at $79.75, traded as high as $81.59 and as low as $79.52, and closed at $80.25. Trading volume was a total of 11.75M shares. On January 17, 2018, GILD opened at $80.71, traded as high as $82.07 and as low as $80.21, and closed at $81.74. Trading volume was a total of 11.16M shares. On January 18, 2018, GILD opened at $81.47, traded as high as $81.65 and as low as $80.77, and closed at $81.17. Trading volume was a total of 8.53M shares. On January 19, 2018, GILD opened at $81.30, traded as high as $81.53 and as low as $80.37, and closed at $80.98. Trading volume was a total of 6.96M shares.

GILD Historical Stock Prices By Date:

GILD historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Gilead Sciences shares, starting with a $10,000 purchase of GILD, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 01/22/2008
End date: 01/19/2018
Start price/share: $22.20
End price/share: $80.98
Starting shares: 450.45
Ending shares: 479.92
Dividends reinvested/share: $5.21
Total return: 288.64%
Average Annual Total Return: 14.54%
Starting investment: $10,000.00
Ending investment: $38,866.17
Years: 10.00
Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/22/2008
End date: 01/19/2018
Start price/share: $22.20
End price/share: $80.98
Dividends collected/share: $5.21
Total return: 288.24%
Average Annual Total Return: 14.53%
Starting investment: $10,000.00
Ending investment: $38,832.25
Years: 10.00
Date Close
01/12/2018$79.02
01/16/2018$80.25
01/17/2018$81.74
01/18/2018$81.17
01/19/2018$80.98
GILD is categorized under the Healthcare sector; below are some other companies in the same sector:

GKOS Historical Stock Prices
GLMD Historical Stock Prices
GLPG Historical Stock Prices
GLYC Historical Stock Prices
GMED Historical Stock Prices
GNCA Historical Stock Prices
GNMK Historical Stock Prices
GNMX Historical Stock Prices
GNOW Historical Stock Prices
GNVC Historical Stock Prices

GILD Historical Stock Prices | HistoricalStockPrice.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following . Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; , and .